Norfloxacin

Basic Information


CAS ID: 70458-96-7
Molecular Formula: C16H18FN3O3
Molecular Weight: 319.3 g/mol
Monoisotopic Mass: 319.1332 g/mol
Class: Small Molecule
Natural Product: No
Other Names: NOROXIN | NORFLOXACIN | Baccidal | Quinabic | MK-366 | UTINOR | CHIBROXIN
Analysis: Drug repositioning mechanism analysis

N O OH O F N NH


Compound Structure and Identifier


InChI: InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) See All
InChI Key: OGJPXUAPXNRGGI-UHFFFAOYSA-N
Smiles: CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCNCC3 See All
Molfile: Download


Related Target



Related Fibrosis Property


Trial Record 1

ClinicalTrial ID NCT01134692 Disease Liver fibrosis
Phase Phase 3 Status Unknown
First Received June 2, 2010 Last Verified June 2, 2010
Sponsor Govind Ballabh Pant Hospital

Trial Record 2

ClinicalTrial ID NCT01037959 Disease Liver fibrosis
Phase Phase 3 Status Terminated
First Received December 23, 2009 Last Verified December 9, 2015
Sponsor Assistance Publique - Hôpitaux de Paris

Trial Record 3

ClinicalTrial ID NCT00678613 Disease Liver fibrosis
Phase Phase 2,Phase 3 Status Unknown
First Received May 15, 2008 Last Verified May 15, 2008
Sponsor All India Institute of Medical Sciences, New Delhi

Trial Record 4

ClinicalTrial ID NCT00359853 Disease Liver fibrosis
Phase Phase 4 Status Completed
First Received August 3, 2006 Last Verified August 3, 2006
Sponsor Hospital Clinic of Barcelona

Related Link


PubChem: 6919051
ChEMBL: CHEMBL9